设为首页 加入收藏

TOP

TEMODAR capsule(三十三)
2013-08-05 18:27:20 来源: 作者: 【 】 浏览:20840次 评论:0
05 1 CAPSULE in 1 PACKET This package is contained within the CARTON (0085-1366-04)
Marketing Information 
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021029 08/11/1999 
TEMODAR temozolomide capsule 
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0085-1425
Route of Administration ORAL DEA Schedule 
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Temozolomide (Temozolomide)  Temozolomide 140 mg
Inactive Ingredients
Ingredient Name Strength
anhydrous lactose  246 mg
silicon dioxide  0.4 mg
sodium starch glycolate type A potato  21 mg
tartaric acid  4.2 mg
stearic acid  8.4 mg
shellac  
alcohol  
isopropyl alcohol  
butyl alcohol  
propylene glycol  
water  
ammonia  
potassium hydroxide  
ferric oxide red  
gelatin  
sodium lauryl sulfate  
FD&C Blue No. 2  
Product Characteristics
Color BLUE, WHITE Score no score
Shape CAPSULE Size 20mm
Flavor  Imprint Code TEMODAR;140;mg
Contains 
Packaging
Item Code Package Description Multilevel Packaging
1  NDC:0085-1425-01 1 BOTTLE, GLASS in 1 CARTON contains a BOTTLE, GLASS
1   5 CAPSULE in 1 BOTTLE, GLASS This package is contained within the CARTON (0085-1425-01)
2  NDC:0085-1425-02 1 BOTTLE, GLASS in 1 CARTON contains a BOTTLE, GLASS
2   14 CAPSULE in 1 BOTTLE, GLASS This package is contained within the CARTON (0085-1425-02)
3  NDC:0085-1425-03 5 PACKET in 1 CARTON contains a PACKET (0085-1425-05)
3  NDC:0085-1425-05 1 CAPSULE in 1 PACKET This package is contained within the CARTON (0085-1425-03)
4  NDC:0085-1425-04 14 PACKET in 1 CARTON contains a PACKET (0085-1425-05)
4  NDC:0085-1425-05 1 CAPSULE in 1 PACKET This package is contained within the CARTON (0085-1425-04)
Marketing Information 
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
NDA NDA021029 08/11/1999 
TEMODAR temozolomide capsule 
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:0085-1430
Route of Administration ORAL DEA Schedule 
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
Temozolomide (Temozolomide)  Temozolomide 180 mg
Inactive Ingredients
Ingredient Name Strength
anhydrous lactose  316.3 mg
silicon dioxide  0.5 mg
sodium starch glycolate type A potato  27 mg
tartaric acid  5.4 mg
stearic acid  10.8 mg
shellac  
alcohol  
isopropyl alcohol  
butyl alcohol  
propylene glycol  
water  
ammonia  
potassium hydroxide  
ferric oxide red  
gelatin  
ferric oxide yellow  
titanium dioxide  
sodium lauryl sulfate  
Product Characteristics
Color ORANGE, WHITE Score no score
Shape CAPSULE Size 20mm
Flavor  Imprint Code TEMODAR;180;mg
Co
以下是“全球医药”详细资料
Tags: 责任编辑:admin
首页 上一页 30 31 32 33 34 35 下一页 尾页 33/35/35
】【打印繁体】【投稿】【收藏】 【推荐】【举报】【评论】 【关闭】 【返回顶部
分享到QQ空间
分享到: 
上一篇SOLU-MEDROL(methylprednisolone .. 下一篇TEMODAR (temozolomide)

相关栏目

最新文章

图片主题

热门文章

推荐文章

相关文章

广告位